share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

默沙东 | 4:持股变动声明-董事 Warden Kathy J
美股SEC公告 ·  06/04 15:03
Moomoo AI 已提取核心信息
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
2024年5月31日,诺斯罗普•格鲁曼公司有关人员凯西•J•沃登(Kathy J Warden)执行了一项涉及默沙东 (Merck & Co.,Inc.)普通股的交易。交易后,沃登直接持有默沙东的500股。交易性质和涉及股数未披露,但交易后的持股量表明在药品公司中有重要投资。
2024年5月31日,诺斯罗普•格鲁曼公司有关人员凯西•J•沃登(Kathy J Warden)执行了一项涉及默沙东 (Merck & Co.,Inc.)普通股的交易。交易后,沃登直接持有默沙东的500股。交易性质和涉及股数未披露,但交易后的持股量表明在药品公司中有重要投资。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息